Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Benachour

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Current Pharmaceutical Design|September 17, 2009
Genomics and the prospects of existing and emerging therapeutics for cardiovascular diseasesM Zaiou, H Benachour, J B Marteau, et al.
Journal of Molecular Recognition : JMR|December 6, 2017
Vitronectin (Vn) glycosylation patterned by lectin affinity assays-A potent glycoproteomic tool to discriminate plasma Vn from cancer ascites VnH Benachour, J Leroy-Dudal, R Agniel, et al.
IEEE Transactions on Nanobioscience|April 4, 2015
A Model-Based Pharmacokinetics Characterization Method of Engineered Nanoparticles for Pilot StudiesJean-Baptiste Tylcz, T Bastogne, H Benachour, et al.
Personalized Medicine|May 26, 2018
From human genetic variations to prediction of risks and responses to drugs and the environmentGérard Siest, B Bastien, H Benachour, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 7, 2009
Association of human cathelicidin (hCAP-18/LL-37) gene expression with cardiovascular disease risk factorsH Benachour, M Zaiou, A Samara, et al.
International Journal of Pharmaceutics|December 21, 2013
Liposome encapsulation of curcumin: physico-chemical characterizations and effects on MCF7 cancer cell proliferationM Hasan, N Belhaj, H Benachour, et al.
Current Medicinal Chemistry|January 5, 2012
Non polymeric nanoparticles for photodynamic therapy applications: recent developmentsR Chouikrat, A Seve, R Vanderesse, et al.
Current Medicinal Chemistry|September 18, 2012
Photodynamic molecular beacons triggered by MMP-2 and MMP-9: influence of the distance between photosensitizer and quencher onto photophysical properties and enzymatic activationM Verhille, H Benachour, A Ibrahim, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Current Pharmaceutical Design|September 17, 2009
Genomics and the prospects of existing and emerging therapeutics for cardiovascular diseasesM Zaiou, H Benachour, J B Marteau, et al.
Journal of Molecular Recognition : JMR|December 6, 2017
Vitronectin (Vn) glycosylation patterned by lectin affinity assays-A potent glycoproteomic tool to discriminate plasma Vn from cancer ascites VnH Benachour, J Leroy-Dudal, R Agniel, et al.
IEEE Transactions on Nanobioscience|April 4, 2015
A Model-Based Pharmacokinetics Characterization Method of Engineered Nanoparticles for Pilot StudiesJean-Baptiste Tylcz, T Bastogne, H Benachour, et al.
Personalized Medicine|May 26, 2018
From human genetic variations to prediction of risks and responses to drugs and the environmentGérard Siest, B Bastien, H Benachour, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 7, 2009
Association of human cathelicidin (hCAP-18/LL-37) gene expression with cardiovascular disease risk factorsH Benachour, M Zaiou, A Samara, et al.
International Journal of Pharmaceutics|December 21, 2013
Liposome encapsulation of curcumin: physico-chemical characterizations and effects on MCF7 cancer cell proliferationM Hasan, N Belhaj, H Benachour, et al.
Current Medicinal Chemistry|January 5, 2012
Non polymeric nanoparticles for photodynamic therapy applications: recent developmentsR Chouikrat, A Seve, R Vanderesse, et al.
Current Medicinal Chemistry|September 18, 2012
Photodynamic molecular beacons triggered by MMP-2 and MMP-9: influence of the distance between photosensitizer and quencher onto photophysical properties and enzymatic activationM Verhille, H Benachour, A Ibrahim, et al.
Pageof 1